LENZ Therapeutics (LENZ) News Today $39.68 -0.32 (-0.80%) Closing price 04:00 PM EasternExtended Trading$39.30 -0.38 (-0.95%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock LENZ Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period FDA Approves Eye Drops That Fix Near Vision Without Glasses1 hour ago | yahoo.comLENZ Therapeutics to Present at Upcoming Investor and Medical ConferencesAugust 25 at 10:18 AM | markets.businessinsider.comWill FDA Approval of Vizz Eye Drops Change LENZ Therapeutics' (LENZ) Narrative?August 21, 2025 | finance.yahoo.comNew FDA approved eye drops for vision is coming soonAugust 19, 2025 | msn.comLord Abbett & CO. LLC Makes New Investment in LENZ Therapeutics, Inc. (NASDAQ:LENZ)August 19, 2025 | marketbeat.comNo Need For Reading Glasses? Vizz Eye Drop That Improves Near Vision Has FDA NodAugust 18, 2025 | msn.comLENZ Therapeutics, Inc. (NASDAQ:LENZ) Receives $49.60 Consensus Target Price from BrokeragesAugust 18, 2025 | americanbankingnews.comLENZ Therapeutics (NASDAQ:LENZ) Sees Unusually-High Trading Volume - Time to Buy?August 17, 2025 | marketbeat.comLENZ Therapeutics, Inc. (NASDAQ:LENZ) Given Consensus Recommendation of "Buy" by BrokeragesAugust 16, 2025 | marketbeat.comFDA Approves Vizz, First Daily Eye Drop For Age-Related Blurry VisionAugust 15, 2025 | msn.comLENZ Therapeutics Scores Relative Strength Rating UpgradeAugust 14, 2025 | msn.comLENZ Therapeutics (NASDAQ:LENZ) Trading Down 7.6% - Should You Sell?August 14, 2025 | marketbeat.comLENZ Therapeutics (NASDAQ:LENZ) Reaches New 52-Week High - Still a Buy?August 12, 2025 | marketbeat.comWilliam Blair Sticks to Their Buy Rating for LENZ Therapeutics (LENZ)August 10, 2025 | theglobeandmail.comNow you don’t need reading glasses, new FDA-approved eye drops can sharpen near visionAugust 9, 2025 | msn.comLENZ Therapeutics Shows Rising Price Performance With Jump To 85 RS RatingAugust 8, 2025 | msn.comDitch your glasses - breakthrough eye drops approved by FDA to fix your near vision instantlyAugust 8, 2025 | msn.comWestfield Capital Management Co. LP Invests $261,000 in LENZ Therapeutics, Inc. (NASDAQ:LENZ)August 7, 2025 | marketbeat.comLENZ Therapeutics (LENZ) Expected to Announce Earnings on WednesdayAugust 7, 2025 | marketbeat.comStocks With Rising Relative Price Strength: LENZ TherapeuticsAugust 7, 2025 | msn.comLENZ Therapeutics (NASDAQ:LENZ) Shares Down 3.6% - Time to Sell?August 5, 2025 | marketbeat.comFDA Approves Vizz Eye Drops to Improve Near Vision in AdultsAugust 5, 2025 | msn.comTD Asset Management Inc Has $895,000 Holdings in LENZ Therapeutics, Inc. (NASDAQ:LENZ)August 5, 2025 | marketbeat.comHC Wainwright Brokers Boost Earnings Estimates for LENZAugust 4, 2025 | marketbeat.comAnalysts Are Bullish on These Healthcare Stocks: LENZ Therapeutics (LENZ), GE Healthcare Technologies Inc (GEHC)August 3, 2025 | theglobeandmail.comAnalysts Offer Insights on Healthcare Companies: LENZ Therapeutics (LENZ) and Regeneron (REGN)August 3, 2025 | theglobeandmail.comLENZ Therapeutics (NASDAQ:LENZ) Sees Strong Trading Volume on Analyst UpgradeAugust 2, 2025 | marketbeat.comNovel Eye Drops for Age-Related Blurry Vision Win FDA ApprovalAugust 2, 2025 | msn.comWilliam Blair Analysts Lower Earnings Estimates for LENZAugust 2, 2025 | marketbeat.comLENZ Therapeutics (NASDAQ:LENZ) Stock Price Expected to Rise, Raymond James Financial Analyst SaysAugust 1, 2025 | marketbeat.comLENZ Therapeutics Gains FDA Approval for VIZZ Eye DropJuly 31, 2025 | msn.comLenz (LENZ) Q2 Revenue Jumps 604%July 31, 2025 | theglobeandmail.comLenz Therapeutics Prepares for LNZ100 LaunchJuly 31, 2025 | msn.comLenz Therapeutics stock rises after FDA approves presbyopia eye dropsJuly 31, 2025 | za.investing.comLENZ Therapeutics Announces US FDA Approval of VIZZ™ for the Treatment of PresbyopiaJuly 31, 2025 | globenewswire.comLENZ Therapeutics (NASDAQ:LENZ) Issues Quarterly Earnings ResultsJuly 31, 2025 | marketbeat.comFY2025 EPS Estimate for LENZ Therapeutics Boosted by AnalystJuly 31, 2025 | marketbeat.comLENZ Therapeutics shares climb as FDA review of presbyopia treatment stays on scheduleJuly 30, 2025 | msn.comLENZ Therapeutics shares surge as FDA review of presbyopia drug on trackJuly 30, 2025 | investing.comLENZ Therapeutics: Undervalued Ahead Of PDUFAJuly 29, 2025 | seekingalpha.comLENZ Therapeutics gains on NDA submission in China for presbyopia drug LNZ100July 28, 2025 | msn.comLENZ Therapeutics (NASDAQ:LENZ) Shares Gap Up - What's Next?July 28, 2025 | marketbeat.comHC Wainwright Issues Positive Forecast for LENZ Therapeutics (NASDAQ:LENZ) Stock PriceJuly 28, 2025 | marketbeat.comLENZ Therapeutics Announces NMPA Submission of New Drug Application for LNZ100 in China for the Treatment of PresbyopiaJuly 28, 2025 | globenewswire.comLENZ Therapeutics (NASDAQ:LENZ) Trading Down 6.6% - Time to Sell?July 26, 2025 | marketbeat.comDell, Bitfarms, Bloom Energy, and More Stocks See Action From Activist InvestorsJuly 25, 2025 | msn.comLENZ Therapeutics, Inc. (NASDAQ:LENZ) Given Consensus Recommendation of "Buy" by AnalystsJuly 21, 2025 | marketbeat.comLeerink Partnrs Has Bearish Outlook for LENZ FY2028 EarningsJuly 14, 2025 | marketbeat.comLENZ Therapeutics (NASDAQ:LENZ) Stock Price Down 5.9% - Should You Sell?July 10, 2025 | marketbeat.comLENZ Therapeutics (NASDAQ:LENZ) Trading Up 8.7% - What's Next?July 9, 2025 | marketbeat.com Get LENZ Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for LENZ and its competitors with MarketBeat's FREE daily newsletter. Email Address LENZ Media Mentions By Week LENZ Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LENZ News Sentiment▼0.760.70▲Average Medical News Sentiment LENZ News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LENZ Articles This Week▼43▲LENZ Articles Average Week Get LENZ Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for LENZ and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ACAD News Today PCVX News Today AAPG News Today ACLX News Today ADMA News Today ZLAB News Today AKRO News Today TLX News Today PTCT News Today LNTH News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LENZ) was last updated on 8/25/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LENZ Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LENZ Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access